Addiction Medicine: Beyond the Abstract

The language used to describe people with substance use disorder impacts stigma and influences clinical decision-making. Host Dr. Shawn McNeil, MD discusses with Dr. Scott G. Weiner, MD the presence of stigmatizing language in clinical notes and detects patient- and provider-level differences.

The language used to describe people with substance use disorder impacts stigma and influences clinical decision-making. Host Dr. Shawn McNeil, MD discusses with Dr. Scott G. Weiner, MD the presence of stigmatizing language in clinical notes and detects patient- and provider-level differences.
 
Based on original research published in the Journal of Addiction Medicine
July/August 2023 - Volume 17 - Issue 4
 
The Incidence and Disparities in Use of Stigmatizing Language in Clinical Notes for Patients With Substance Use Disorder

Examining the Primary Care Experience of Patients With Opioid Use Disorder: A Qualitative Study
In episode 26 of Addiction Medicine: Beyond the Abstract, host Shawn McNeil, MD, is joined by Michael Incze, MD, MSEd. Dr. Incze is a primary care physician at the University of Utah Health Division of General Internal Medicine. He is board certified in internal health and addiction medicine. Dr. Incze will discuss the advantages of primary care-based SUD treatment, focusing on both the perspective of patients and clinicians.
 
Journal of Addiction Medicine, July/August 2023
 
https://journals.lww.com/journaladdictionmedicine/pages/articleviewer.aspx?year=2023&issue=07000&article=00009&type=Fulltext&context=featuredarticles&collectionid=1

Meet JAM Editor-in-Chief, David A. Fiellin, MD, FASAM
 
Dr. Fiellin is an internist, board certified in addiction medicine. He is professor of Medicine and Emergency Medicine at Yale School of Medicine, and Public Health at Yale School of Public Health; vice chief of Faculty Affairs for the Department of Internal Medicine’s Section of General Internal Medicine; and serves as the inaugural director of the Program in Addiction Medicine at Yale.
Dr. Fiellin has focused his scholarly work on improving access to and the quality of substance use prevention and treatment, especially in general healthcare settings. His research focuses on the efficacy, effectiveness, and implementation of treatments for opioid use disorder and alcohol use disorder in office-based, primary care, Emergency Department, hospital, obstetrical and gynecologic practices, and HIV specialty settings. He has served and is serving as principal investigator and co-investigator on multiple NIH-funded research projects using a variety of research designs including clinical trials, observational studies, pharmacoepidemiology, qualitative methods, and implementation science. His work has been published in journals that include NEJM, JAMA, The Lancet, Annals of Internal Medicine, and BMJ.

In episode twenty-four of Addiction Medicine: Beyond the Abstract, host Shawn McNeil, MD is joined by Dr. Jed Barash, a Neurologist from Massachusetts. In his paper, Dr. Barash and his colleagues discuss using an existing syndromic surveillance system to monitor for possible cases of opioid-associated amnestic syndrome in the state of Massachusetts.
 
Article: LINK
Guest Twitter: @JedBarash

In episode twenty two of Addiction Medicine: Beyond the Abstract, host Shawn McNeil, MD, is joined by Amy Kennedy, MD, MS. Dr. Kennedy is an Acting Assistant Professor of Medicine at the University of Washington and Director of GMS Addiction Medicine Program at the VA Puget Sound Healthcare System. In her paper, Dr. Kennedy discusses barriers and facilitators of the prescription of HIV preexposure prophylaxis to high-risk injection drug users by buprenorphine prescribers.
Journal of Addiction Medicine, May/June 2021
Article Link
Twitter: @AmyJoKennedy

February 14, 2022
In episode twenty-three of Addiction Medicine: Beyond the Abstract, host Shawn McNeil, MD is joined by Catalina Lopez-Quintero, MD, PhD, MPH. Dr. Lopez-Quintero is an Assistant Professor of Epidemiology at the University of Florida. In her paper, Dr. Lopez-Quintero discusses racial-ethnic differences in reasons for misuse of prescription medications among a nationally representative sample of US adults.

Addiction Medicine: Beyond the Abstract (Episode 21). Host Shawn McNeil, MD, is joined by Simeon Kimmel, MD, who discusses a trend of referral rejections for post-acute medical care among patients with substance use disorders and patients receiving opioid agonist treatment Dr. Kimmel (@simkimmel) is an Assistant Professor of Medicine at Boston University School of Medicine and Attending Physician at Boston Medical Center.
Journal of Addiction Medicine, January/February 2021, Rejection of Patients With Opioid Use Disorder Referred for Post-acute Medical Care Before and After an Anti-discrimination Settlement in Massachusetts.

In episode 20 of Addiction Medicine: Beyond the Abstract, we are joined by Tami Mark, PhD. She is a Senior Fellow of Behavioral Health Financing and Quality Measurement for RTI International. Dr. Mark discusses patient placement criteria for addiction treatment and multidimensional assessments, which was published in the March/April 2021 issue of Journal of Addiction Medicine. Article: LINK

In episode 19 of Addiction Medicine: Beyond the Abstract, we are joined by MacKenzie Peltier, PhD. She is an Assistant Professor of Psychiatry at Yale School of Medicine. In her paper, Dr. Peltier discusses sex-specific vulnerabilities observed among individuals with opioid use disorder.